K Truninger
Overview
Explore the profile of K Truninger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menigatti M, Truninger K, Gebbers J, Marbet U, Marra G, Schar P
Oncogene
. 2008 Dec;
28(6):899-909.
PMID: 19060925
Silencing of gene expression by aberrant cytosine methylation is a prominent feature of human tumors, including colorectal cancers. Epigenetic changes of this type play undisputed roles in cell transformation when...
2.
Schmidtko J, Truninger K, Gugger M, Cottagnoud P, Stucki A
Praxis (Bern 1994)
. 2008 Jun;
97(3):117-8.
PMID: 18549011
No abstract available.
3.
Truninger K
Ther Umsch
. 2007 Aug;
64(4):205-10.
PMID: 17663206
Irritable bowel syndrome (IBS) is one of the most frequent functional gastrointestinal disorders. The main symptoms are abdominal pain associated with a change in bowel habit. Headache and psychiatric disorders...
4.
Te Morsche R, Drenth J, Truninger K, Schulz H, Kage A, Landt O, et al.
Pharmacogenomics J
. 2007 Feb;
8(1):34-41.
PMID: 17325733
UDP-glucuronosyltransferases (UGT) catalyze the glucuronidation of various compounds and thus inactivate toxic substrates. Genetic variations reducing the activity of UGT1A7 have been associated with various gastrointestinal cancers. Most recently, the...
5.
Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study
Mullhaupt B, Truninger K, Ammann R
Z Gastroenterol
. 2005 Nov;
43(12):1293-301.
PMID: 16315124
Background And Aim: This prospective study aimed to investigate the impact of etiology on the pain profile in relation to alterations of function and morphology from early to advanced chronic...
6.
Verlaan M, Drenth J, Truninger K, Koudova M, Schulz H, Bargetzi M, et al.
J Med Genet
. 2005 Oct;
42(10):e62.
PMID: 16199544
Background: Xenobiotic mediated cellular injury is thought to play a major role in the pathogenesis of pancreatic diseases. Genetic variations that reduce the expression or activity of detoxifying phase II...
7.
Johnson V, Volikos E, Halford S, Eftekhar Sadat E, Popat S, Talbot I, et al.
Gut
. 2005 Jan;
54(2):264-7.
PMID: 15647192
Background And Aims: Activating beta-catenin mutations in exon 3 have been implicated in colorectal tumorigenesis. Although reports to the contrary exist, it has been suggested that beta-catenin mutations occur more...
8.
Truninger K, Ammann R, Blum H, Witt H
Swiss Med Wkly
. 2002 Jan;
131(39-40):565-74.
PMID: 11775491
The recent genetic discoveries in CP support the hypothesis that inappropriate intrapancreatic activation of zymogens by trypsin results in autodigestion and pancreatitis. Two different protective mechanisms prevent activation of the...
9.
Truninger K, Malik N, Ammann R, Muellhaupt B, Seifert B, Muller H, et al.
Am J Gastroenterol
. 2001 Sep;
96(9):2657-61.
PMID: 11569691
Objective: Several studies have reported an increased frequency of cystic fibrosis gene mutations in idiopathic but not in alcoholic chronic pancreatitis. The impact of cystic fibrosis gene mutations on the...
10.
Zimmerli L, Yurtsever H, Conen D, Truninger K
Lancet
. 2001 Jun;
357(9269):1670.
PMID: 11425372
No abstract available.